BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu Y, Carradori D, Alhouayek M, Muccioli GG, Cani PD, Préat V, Beloqui A. Size Effect on Lipid Nanocapsule-Mediated GLP-1 Secretion from Enteroendocrine L Cells. Mol Pharmaceutics 2018;15:108-15. [DOI: 10.1021/acs.molpharmaceut.7b00742] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Mwema A, Bottemanne P, Paquot A, Ucakar B, Vanvarenberg K, Alhouayek M, Muccioli GG, des Rieux A. Lipid nanocapsules for the nose-to-brain delivery of the anti-inflammatory bioactive lipid PGD(2)-G. Nanomedicine 2022;48:102633. [PMID: 36435364 DOI: 10.1016/j.nano.2022.102633] [Reference Citation Analysis]
2 Ibnat N, Zaman R, Uddin MB, Chowdhury E, Lee CY. Improved systemic half-life of glucagon-like peptide-1-loaded carbonate apatite nanoparticles in rats. World J Diabetes 2022; 13(8): 613-621 [DOI: 10.4239/wjd.v13.i8.613] [Reference Citation Analysis]
3 Lok KH, Wareham NJ, Nair RS, How CW, Chuah LH. Revisiting The Concept of Incretin and Enteroendocrine L-cells as Type 2 Diabetes Mellitus Treatment. Pharmacol Res 2022;:106237. [PMID: 35487405 DOI: 10.1016/j.phrs.2022.106237] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Labrak Y, Heurtault B, Frisch B, Saulnier P, Lepeltier E, Miron VE, Muccioli GG, des Rieux A. Impact of anti-PDGFRα antibody surface functionalization on LNC uptake by oligodendrocyte progenitor cells. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Xu B, Chen SL, Zhang Y, Li B, Yuan Q, Gan W. Evaluating the cross-membrane dynamics of a charged molecule on lipid films with different surface curvature. J Colloid Interface Sci 2021;610:376-84. [PMID: 34923275 DOI: 10.1016/j.jcis.2021.12.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Pan L, Xu M, Wang Q, Zou X, Han Y, Zhou Z. Long-term drench of exopolysaccharide from Leuconostoc pseudomesenteroides XG5 protects against type 1 diabetes of NOD mice via stimulating GLP-1 secretion. J Sci Food Agric 2021. [PMID: 34558071 DOI: 10.1002/jsfa.11541] [Reference Citation Analysis]
7 Qin W, Ying W, Hamaker B, Zhang G. Slow digestion-oriented dietary strategy to sustain the secretion of GLP-1 for improved glucose homeostasis. Compr Rev Food Sci Food Saf 2021. [PMID: 34350681 DOI: 10.1111/1541-4337.12808] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
8 Xu Y, Shrestha N, Préat V, Beloqui A. An overview of in vitro, ex vivo and in vivo models for studying the transport of drugs across intestinal barriers. Adv Drug Deliv Rev 2021;175:113795. [PMID: 33989702 DOI: 10.1016/j.addr.2021.05.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
9 Eissa NG, Elsabahy M, Allam A. Engineering of smart nanoconstructs for delivery of glucagon-like peptide-1 analogs. Int J Pharm 2021;597:120317. [PMID: 33540005 DOI: 10.1016/j.ijpharm.2021.120317] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
10 Plaza-Oliver M, Santander-Ortega MJ, Lozano MV. Current approaches in lipid-based nanocarriers for oral drug delivery. Drug Deliv Transl Res 2021;11:471-97. [PMID: 33528830 DOI: 10.1007/s13346-021-00908-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 17.5] [Reference Citation Analysis]
11 Abeer MM, Rewatkar P, Qu Z, Talekar M, Kleitz F, Schmid R, Lindén M, Kumeria T, Popat A. Silica nanoparticles: A promising platform for enhanced oral delivery of macromolecules. Journal of Controlled Release 2020;326:544-55. [DOI: 10.1016/j.jconrel.2020.07.021] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 16.0] [Reference Citation Analysis]
12 Yadava SK, Basu SM, Valsalakumari R, Chauhan M, Singhania M, Giri J. Curcumin-Loaded Nanostructure Hybrid Lipid Capsules for Co-eradication of Breast Cancer and Cancer Stem Cells with Enhanced Anticancer Efficacy. ACS Appl Bio Mater 2020;3:6811-22. [DOI: 10.1021/acsabm.0c00764] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
13 Xu Y, De Keersmaecker H, Braeckmans K, De Smedt S, Cani PD, Préat V, Beloqui A. Targeted nanoparticles towards increased L cell stimulation as a strategy to improve oral peptide delivery in incretin-based diabetes treatment. Biomaterials 2020;255:120209. [PMID: 32580098 DOI: 10.1016/j.biomaterials.2020.120209] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
14 Xu Y, Shrestha N, Préat V, Beloqui A. Overcoming the intestinal barrier: A look into targeting approaches for improved oral drug delivery systems. Journal of Controlled Release 2020;322:486-508. [DOI: 10.1016/j.jconrel.2020.04.006] [Cited by in Crossref: 62] [Cited by in F6Publishing: 69] [Article Influence: 20.7] [Reference Citation Analysis]
15 Xu Y, Van Hul M, Suriano F, Préat V, Cani PD, Beloqui A. Novel strategy for oral peptide delivery in incretin-based diabetes treatment. Gut 2020;69:911-9. [PMID: 31401561 DOI: 10.1136/gutjnl-2019-319146] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 8.7] [Reference Citation Analysis]
16 Durán-Lobato M, Niu Z, Alonso MJ. Oral Delivery of Biologics for Precision Medicine. Adv Mater 2020;32:e1901935. [PMID: 31222910 DOI: 10.1002/adma.201901935] [Cited by in Crossref: 56] [Cited by in F6Publishing: 65] [Article Influence: 18.7] [Reference Citation Analysis]
17 Yu Z, Fan W, Wang L, He H, Lv Y, Qi J, Lu Y, Wu W. Slowing down lipolysis significantly enhances the oral absorption of intact solid lipid nanoparticles. Biomater Sci 2019;7:4273-82. [PMID: 31407729 DOI: 10.1039/c9bm00873j] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
18 Bak A, Ashford M, Brayden DJ. Local delivery of macromolecules to treat diseases associated with the colon. Adv Drug Deliv Rev 2018;136-137:2-27. [PMID: 30359631 DOI: 10.1016/j.addr.2018.10.009] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 10.0] [Reference Citation Analysis]